Newbridge Financial Services Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9
Closed -$2K 1425
2021
Q1
$2K Hold
9
﹤0.01% 1153
2020
Q4
$3K Hold
9
﹤0.01% 904
2020
Q3
$2K Buy
+9
New +$2.05K ﹤0.01% 905

Other funds holding AMED

Newbridge Financial Services Group's AMED Position: Q2 2021 in Review

Newbridge Financial Services Group sold out of Amedisys (AMED) in Q2 2021, closing a stake of 9 shares — an estimated $2K sold.

Newbridge Financial Services Group first reported a position in AMED in Q3 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Newbridge Financial Services Group reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Newbridge Financial Services Group sold 9 Amedisys shares in Q2 2021, an estimated $2K.
  • Newbridge Financial Services Group first reported a position in Amedisys in Q3 2020 and held it in 3 quarters.
  • Newbridge Financial Services Group's Amedisys position peaked at $3K in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Newbridge Financial Services Group's 13F filing for Q2 2021, filed 7 Sep 2021.